G

Genoray Co Ltd
KOSDAQ:122310

Watchlist Manager
Genoray Co Ltd
KOSDAQ:122310
Watchlist
Price: 4 230 KRW -1.28% Market Closed
Market Cap: 61.5B KRW

Genoray Co Ltd
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Genoray Co Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
G
Genoray Co Ltd
KOSDAQ:122310
Revenue
â‚©104.9B
CAGR 3-Years
8%
CAGR 5-Years
9%
CAGR 10-Years
N/A
J
Jeisys Medical Inc
KOSDAQ:287410
Revenue
â‚©167.8B
CAGR 3-Years
64%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Classys Inc
KOSDAQ:214150
Revenue
â‚©294.2B
CAGR 3-Years
36%
CAGR 5-Years
30%
CAGR 10-Years
N/A
W
Won Tech Co Ltd
KOSDAQ:336570
Revenue
â‚©115.3B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Seers Technology Co Ltd
KOSDAQ:458870
Revenue
â‚©8.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
N
NextBioMedical Co Ltd
KOSDAQ:389650
Revenue
â‚©9.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Genoray Co Ltd
Glance View

Market Cap
61.5B KRW
Industry
Health Care

Genoray Co., Ltd. manufactures medical and dental digital x-radiation systems. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2018-05-28. The firm operates its business through two segments. The Medical segment manufactures and sells mobile C-arm and mammography equipments. The Dental segment manufactures and sells panoramic equipment, cephalometry equipment, 3D computed tomography (CT), portable X-ray equipment.

Intrinsic Value
7 685.63 KRW
Undervaluation 45%
Intrinsic Value
Price
G

See Also

What is Genoray Co Ltd's Revenue?
Revenue
104.9B KRW

Based on the financial report for Jun 30, 2025, Genoray Co Ltd's Revenue amounts to 104.9B KRW.

What is Genoray Co Ltd's Revenue growth rate?
Revenue CAGR 5Y
9%

Over the last year, the Revenue growth was -3%. The average annual Revenue growth rates for Genoray Co Ltd have been 8% over the past three years , 9% over the past five years .

Back to Top